The Future Of Clinical Evidence Requirements For Medical Devices in the EU
This article was originally published in SRA
The Council of the European Union’s agreed amendments to the requirements for clinical evaluation reports under the new Medical Device Regulation are substantial. And so are its proposed amendments to clinical investigations and post-market clinical follow up. Sarah Sorrel explains why these amendments are likely to become reality, how companies may be required to adjust and what demands they will have to meet.